Search This Blog

Thursday, August 6, 2026

Insmed lifts long-term peak annual revenue forecast for BRINSUPRI, TPIP and ARIKAYCE to over $14B

 

Insmed lifts long-term peak annual revenue forecast for BRINSUPRI, TPIP and ARIKAYCE to over $14B after strong Q2 results

  • Insmed reported Q2 2026 non-GAAP EPS $-0.06 and revenue $425.5M (+296% YoY), beating EPS and revenue estimates.
  • Raised 2026 BRINSUPRI sales guidance to $1.25–$1.40B following strong Q2 BRINSUPRI performance.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)